We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 8 maart 2018

British Journal of Cancer - Table of Contents alert Volume 118 Issue 5

If you are unable to see the message below, click here to view.
British Journal of Cancer

Volume 118, Issue 5 (March 2018)

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Letters to the Editor
Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Breast Cancer Now Catalyst Programme Grants 
Apply now 

We are inviting Expressions of Interest from researchers who are interested in using Pfizer drugs for preclinical or clinical breast cancer research from teams based at a single site or multiple sites in the UK and Europe. To apply please visit our website.


EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting

Habeeb Majeed & Eitan Amir

British Journal of Cancer 2018 118 :617 - 618; February 22, 2018; 10.1038/bjc.2017.427


Abstract | Full Text


Reporting guidelines for oncology research: helping to maximise the impact of your research

Angela MacCarthy, Shona Kirtley, Jennifer A de Beyer, Douglas G Altman & Iveta Simera

British Journal of Cancer 2018 118 :619 - 628; February 22, 2018; 10.1038/bjc.2017.407


Abstract | Full Text

Clinical Studies

Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)

S Rim Kim, Nan Song, Greg Yothers, Patrick G Gavin, Carmen J Allegra et al.

British Journal of Cancer 2017 118 :629 - 633; December 14, 2017; 10.1038/bjc.2017.448


Abstract | Full Text

Indeterminate nodules in osteosarcoma: what's the follow-up?

K M Ghosh, L H Lee, T B Beckingsale, C H Gerrand & K S Rankin

British Journal of Cancer 2018 118 :634 - 638; January 30, 2018; 10.1038/bjc.2017.453


Abstract | Full Text

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer

Maite Antonio, Juana Saldaña, Jennifer Linares, José C Ruffinelli, Ramón Palmero et al.

British Journal of Cancer 2018 118 :639 - 647; January 30, 2018; 10.1038/bjc.2017.455


Abstract | Full Text

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)

Jong-Mu Sun, Ki Hyeong Lee, Bong-Seog Kim, Hoon-Gu Kim, Young Joo Min et al.

British Journal of Cancer 2018 118 :648 - 653; January 30, 2018; 10.1038/bjc.2017.465


Abstract | Full Text

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

Baohui Han, Kai Li, Yizhuo Zhao, Baolan Li, Ying Cheng et al.

British Journal of Cancer 2018 118 :654 - 661; February 13, 2018; 10.1038/bjc.2017.478


Abstract | Full Text

KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study

Yutaka Nakano, Minoru Kitago, Sachiko Matsuda, Yuki Nakamura, Yusuke Fujita et al.

British Journal of Cancer 2018 118 :662 - 669; January 23, 2018; 10.1038/bjc.2017.479


Abstract | Full Text

Translational Therapeutics

WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages

Geun Taek Lee, Seok Joo Kwon, Jongmyung Kim, Young Suk Kwon, Nara Lee et al.

British Journal of Cancer 2018 118 :670 - 678; January 30, 2018; 10.1038/bjc.2017.451


Abstract | Full Text

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

Marie Viala, Marie Vinches, Marie Alexandre, Caroline Mollevi, Anna Durigova et al.

British Journal of Cancer 2018 118 :679 - 697; February 13, 2018; 10.1038/bjc.2017.473


Abstract | Full Text

Molecular Diagnostics

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Laura Forker, Piers Gaunt, Stefano Sioletic, Patrick Shenjere, Robert Potter et al.

British Journal of Cancer 2017 118 :698 - 704; December 12, 2017; 10.1038/bjc.2017.430


Abstract | Full Text

The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer

Meera Patel, Stephen T McSorley, James H Park, Campbell S D Roxburgh, Joann Edwards et al.

British Journal of Cancer 2018 118 :705 - 712; January 16, 2018; 10.1038/bjc.2017.441


Abstract | Full Text

Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein

Urszula L McClurg, Arash Nabbi, Charles Ricordel, Svitlana Korolchuk, Stuart McCracken et al.

British Journal of Cancer 2018 118 :713 - 726; January 30, 2018; 10.1038/bjc.2017.447


Abstract | Full Text

Genetics & Genomics

Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel

Ceres Fernandez-Rozadilla, Christiana Kartsonaki, Connor Woolley, Michael McClellan, Deb Whittington et al.

British Journal of Cancer 2018 118 :727 - 732; February 13, 2018; 10.1038/bjc.2017.486


Abstract | Full Text


Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009–2013? Implications for use of the data in research

C Di Girolamo, S Walters, C Gildea, S Benitez Majano, M P Coleman et al.

British Journal of Cancer 2018 118 :733 - 737; January 18, 2018; 10.1038/bjc.2017.452


Abstract | Full Text

Loss in working years after a breast cancer diagnosis

Anna Plym, Hannah Bower, Irma Fredriksson, Lars Holmberg, Paul C Lambert et al.

British Journal of Cancer 2018 118 :738 - 743; January 23, 2018; 10.1038/bjc.2017.456


Abstract | Full Text

Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study

Caron Strahlendorf, Jason D Pole, Randy Barber, David Dix, Ketan Kulkarni et al.

British Journal of Cancer 2018 118 :744 - 749; January 30, 2018; 10.1038/bjc.2017.462


Abstract | Full Text

External validation of risk prediction models for incident colorectal cancer using UK Biobank

J A Usher-Smith, A Harshfield, C L Saunders, S J Sharp, J Emery et al.

British Journal of Cancer 2018 118 :750 - 759; January 30, 2018; 10.1038/bjc.2017.463


Abstract | Full Text

Letters to the Editor

Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure'

Mohan Doss

British Journal of Cancer 2018 118 : e9; February 13, 2018; 10.1038/bjc.2017.481


Abstract | Full Text

Reply to 'Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure''

Wan-Hua Hsieh, I-Feng Lin, Jung-Chun Ho & Peter Wushou Chang

British Journal of Cancer 2018 118 : e10; February 13, 2018; 10.1038/bjc.2017.490


Abstract | Full Text

Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis'

Rama Jayaraj & Chellan Kumarasamy

British Journal of Cancer 2018 118 : e11; February 15, 2018; 10.1038/bjc.2017.482


Abstract | Full Text

Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis"

Alhadi Almangush, Ilkka Heikkinen, Antti A Mäkitie, Ricardo D Coletta, Esa Läärä et al.

British Journal of Cancer 2018 118 : e12; February 15, 2018; 10.1038/bjc.2017.491


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature